Erudio Healtherudio.com
Sponsor
Women's Cancer Study Group trials: what clinicians said in public
No HCP commentary report on a trial sponsored by Women's Cancer Study Group yet. Erudio has found public clinician commentary on 3 clinical trials sponsored by Women's Cancer Study Group: ADAPTcycle, ADAPTela and PlanB. Each trial's page lists the podcasts, videos and posts found so far and the price of a report.
Listed by lead sponsor as registered on ClinicalTrials.gov (Women's Cancer Study Group GmbH). A trial led by a partner or a research group is on that sponsor's page. Only trials with public clinician commentary found are listed, not every trial the sponsor runs.
| Trial | Indication | Phase | Statements | Sources | Size | Checked | Preview |
|---|---|---|---|---|---|---|---|
| No report yetTrials with public commentary we haven't built a report for. Size is an estimate of the verified statements the commentary we've indexed so far will yield; final coverage is set when we build the report, within 24 hours of your confirmed order. You never pay more than quoted: a report delivered at a smaller size costs that size's price. Some can also be requested as a free preview. | |||||||
| PlanB NCT01049425 · Women's Cancer Study Group GmbH DeepView → | HER2-negative early breast cancer | Phase 3 | Deep | View | |||
| ADAPTcycle NCT04055493 · Women's Cancer Study Group GmbH DeepView → | intermediate-risk HR+/HER2- early breast cancer | Phase 3 | Deep | View | |||
| ADAPTela NCT07242352 · Women's Cancer Study Group GmbH FocusedView → | Not given | Phase 3 | Focused | View | |||